Press release
Cancer Vaccines Market to Reach USD 17.42 Billion by 2030, Fueled by mRNA Innovation and Preventive Programs
Mordor Intelligence has published a new report on the Cancer Vaccines Market, offering a comprehensive analysis of trends, growth drivers, and future projections.The cancer vaccines market is projected to grow from USD 10.67 billion in 2025 to USD 17.42 billion by 2030, at a compound annual growth rate (CAGR) of 10.30% during the forecast period. This growth reflects increasing adoption of both preventive and therapeutic vaccine platforms, supported by advancements in personalized mRNA and neoantigen technologies, as well as government-led HPV immunization programs. North America leads in market size, while Asia‐Pacific shows rapid expansion driven by cost-effective production and rising cancer incidence.
Report Overview: https://www.mordorintelligence.com/industry-reports/cancer-vaccines-market?utm_source=openpr
Key Trends
Shift toward Personalized mRNA and Neoantigen Vaccines
The development of individualized cancer vaccines-tailored to each patient's tumor mutations-is accelerating globally. Predictive AI models are refining epitope selection, and modular manufacturing facilities shorten production timelines.
Preventive Vaccines Dominate Early Adoption
HPV-based cancer prevention vaccines continue to account for the majority of current market revenue, supported by expanding immunization programs and regulatory approvals. Interest in therapeutic vaccine candidates is growing rapidly, fueled by promising clinical data.
mRNA Platforms Lead Growth in Asia-Pacific
While recombinant cancer vaccine types remain established, mRNA and neoantigen platforms are growing fastest in the Asia‐Pacific region. Regional projects in China, India, and South Korea support local vaccine development and distribution capacity at more affordable costs.
Combination Therapies Gain Ground
Cancer vaccines are increasingly studied in combination with checkpoint inhibitors, adoptive cell therapies, and adjuvant regimens to improve durability and efficacy-especially in melanoma, cervical, and pancreatic cancer trials.
Regulatory Alignment Supports Cross‐Border Trials
FDA breakthrough therapy designations, EMA PRIME approvals, and global harmonization of trial standards have reduced barriers to multinational studies and fast-track access to novel cancer vaccine therapies
Market Segmentation
By Technology
Recombinant Vaccines
Viral Vector & DNA Vaccines
mRNA/Neoantigen Personalised Vaccines
Whole-cell & Dendritic Cell Vaccines
Other Technologies
By Treatment Method
Preventive Vaccines
Therapeutic Vaccines
By Cancer Type
Cervical Cancer (HPV)
Prostate Cancer
Melanoma
Other Cancers
By Delivery Route
Intramuscular
Intradermal / Sub-cutaneous
Intravenous
By Region:
North America
Europe
Asia‐Pacific
South America
Middle East & Africa
Explore Our Full Library of Healthcare Industry Research Reports
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr
Key Players
Major companies active in the global cancer vaccines market include:
OSE Immunotherapeutics
GlaxoSmithKline PLC
F Hoffmann-La Roche AG (Genentech)
Moderna Inc.
Merck & Co. Inc.
For more information, visit: https://www.mordorintelligence.com/industry-reports/cancer-vaccines-market/companies?utm_source=openpr
Conclusion
The global cancer vaccines market is on track to expand from USD 10.67 billion in 2025 to USD 17.42 billion by 2030, exhibiting a 10.30% CAGR. Preventive vaccines, especially HPV formulations, continue to dominate current revenues, while therapeutic and personalized vaccine segments are attracting major investment and clinical momentum.
North America remains the largest market, thanks to established health infrastructure and early adoption. Asia‐Pacific, with regional vaccine development capacity, is the fastest-growing region in terms of revenue. Technological shifts toward mRNA and neoantigen platforms, paired with AI-guided design and streamlined regulatory pathways, are accelerating personalized vaccine development.
Industry Related Reports
Asia-Pacific Cancer Vaccines Market: The Asia-Pacific Cancer Vaccines Market is Segmented by Technology (Recombinant Vaccines, and More), Treatment Method (Preventive Vaccines and Therapeutic Vaccines), Cancer Type (Cervical Cancer (HPV), Melanoma and More), Delivery Route (Intramuscular, Intravenous, and More), and Geography (China, Japan, India, and More).
Get More Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-cancer-vaccines-market?utm_source=openpr
Therapeutic Vaccine Market: The Therapeutic Vaccine Market is Segmented by Products (Autoimmune Disease Vaccines, Cancer Vaccines, and More), Technology (Allogeneic Vaccines and Autologous Vaccines), Age Group (Adults and More), Distribution Channel (Public and Private) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/global-therapeutic-vaccines-market-industry?utm_source=openpr
Oncology Based In-Vivo CRO Market: Oncology Based In-Vivo Contract Research Organization (CRO) Market is segmented by Indication (Blood Cancer, Solid Tumors, and Other Indication), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX)), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/oncology-based-in-vivo-cro-market?utm_source=openpr
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Vaccines Market to Reach USD 17.42 Billion by 2030, Fueled by mRNA Innovation and Preventive Programs here
News-ID: 4130546 • Views: …
More Releases from Mordor Intelligence

VNA & PACS Market to Reach USD 6.61 Billion by 2030, Driven by Imaging Volume Gr …
Mordor Intelligence has published a new report on the VNA & PACS Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Vendor-Neutral Archive (VNA) & PACS (Picture Archiving and Communication System) market is forecast to grow from USD 4.59 billion in 2025 to USD 6.61 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.55% during that period. This growth is largely driven by…

Genomics Market Headed to USD 118.67 Billion by 2030, Fueled by Sequencing, AI i …
Mordor Intelligence has published a new report on the Genomics Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The Genomics Market is poised to nearly double, expanding from an expected USD 59.28 billion in 2025 to approximately USD 118.67 billion by 2030, reflecting a robust compound annual growth rate of 14.89%. This remarkable growth stems from widespread adoption of technology in healthcare, agriculture, and research. Researchers,…

Indonesia Commercial Construction Market Set to Reach USD 81.80 Billion by 2030 …
Mordor Intelligence has published a new report on the "Indonesia Commercial Construction Market" offering a comprehensive analysis of trends, growth drivers, and future projections
Introduction:
The Indonesia Commercial Construction Market is witnessing considerable activity and expansion, driven by steady economic growth, increasing foreign investments, and an evolving business landscape. According to a 2025 report on the Indonesia Commercial Construction Market by Mordor Intelligence, the sector is expected to grow from…

Foreign Exchange Market to Reach USD 1.18 Trillion by 2030, Driven by Online Tra …
Mordor Intelligence has published a new report on the "Foreign Exchange Market" offering a comprehensive analysis of trends, growth drivers, and future projections
Introduction
Mordor Intelligence, in its latest foreign exchange market report, forecasts the market to grow from USD 0.89 trillion in 2025 to USD 1.18 trillion by 2030, registering a CAGR of 5.83% during the forecast period. The foreign exchange (forex or FX) market continues to be the…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…